Comparison of Coagulation Factors During Laparoscopic Cholecystectomy

Status Recruiting

Clinical Trial Summary

Pneumoperitoneum is formed with CO2 during laparoscopic abdominal operations. Effect of pneumoperitoneum on coagulation factors is not well known. In our study the investigators aimed to compare the general anesthesia(GA) and combined spinal-epidural anesthesia (CA) during laparoscopic cholecystectomy(LC) with effect on coagulation factors.

Fifty patients will be randomly assigned to either the Laparoscopic cholecystectomy under Combined anaesthesia (25 patients) or Laparoscopic cholecytectomy under general anaesthesia (25 patients). All patients has symptomatic gall stone disease or polyp of gall bladder.

Clinical Trial Description

Objective of study : The aim of this study was to compare general anesthesia (GA) and combined (epidural and spinal) anesthesia (CA) for laparoscopic cholecystectomy(LC).Laparoscopic cholecystectomies are usually performed under general anesthesia. Studies involving cholecystectomies with regional anesthesia recently published. During regional anesthesia pneumoperitoneum is performed with lower pressure(10mmHg CO2). Patients can not tolerate higher intraabdominally pressure. Thera are very few studies involving the effect of pneumoperitoneum on coagulation factors. In our study the investigators separate the patients into 2 groups. Group1:10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia ; Group2 : 10 mmHg pressure, laparoscopic cholecystectomy under Combined Spinal-Epidural Anesthesia The investigators performed standard conventional laparoscopic cholecystectomy procedure with 10mmHg pressure in both groups. The investigators aimed to investigate Prothrombin Time(PT), activated partial thromboplastin time(aPTT), thrombin time(TT), D-dimer and fibrinogen levels preoperative, postoperative 1st hour and 24th hour respectively. ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02568852
Study type	Interventional
Source	Lütfiye Nuri Burat Government Hospital
Contact	Turgut Donmez, Surgeon
Phone	905347400967
Email	surgeont73@hotmail.com
Status	Recruiting
Phase	N/A
Start date	October 2015
Completion date	February 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01749722` - Safety and Efficacy of the NaviAid™ G-Eye System During Colonoscopy	N/A
Completed	`NCT01735266` - Left-colon WEC May Reduce Insertion Time Compared With Whole-colon WEC.	N/A
Completed	`NCT01560377` - Perfusion Assessment in Laparoscopic Left Anterior Resection	Phase 1
Completed	`NCT01124266` - Endoscopy Nurse Participation in Adenoma Detection Rate During Colonoscopy	Phase 4
Completed	`NCT00245492` - Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening.	N/A
Active, not recruiting	`NCT04369053` - Prevention of Colorectal Cancer Through Multiomics Blood Testing
Completed	`NCT02292563` - The Impact of Experienced Endoscopy Nurse Participation on Polyp and Adenoma Detection During Colonoscopy	N/A
Completed	`NCT01552200` - Performance Evaluation of the NaviAid™ G-Eye System	N/A
Completed	`NCT01451008` - Compression Anastomosis Using the Compression Anastomotic Ring-locking Procedure (CARP)	Phase 1
Completed	`NCT02034929` - EndoCuff-assisted Versus Standard Colonoscopy for Adenoma Detection	N/A
Completed	`NCT02317510` - Combined Spinal Epidural Anesthesia and General Anesthesia for Laparoscopic Cholecystectomy	N/A
Completed	`NCT02853695` - Implementation of Hysteroscopy in Flanders and the Netherlands

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.